1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilars/follow-on-biologics Market Size 2016-2026

2.1.2 Biosimilars/follow-on-biologics Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Biosimilars/follow-on-biologics Segment by Type

2.2.1 Human growth hormone

2.2.2 Human growth hormone

2.2.3 Monoclonal antibodies

2.2.4 Insulin

2.2.5 Interferon

2.2.6 Granulocyte-Colony Stimulating Factor

2.2.7 Others

2.3 Biosimilars/follow-on-biologics Market Size by Type

2.3.1 Global Biosimilars/follow-on-biologics Market Size CAGR by Type

2.3.2 Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

2.4 Biosimilars/follow-on-biologics Segment by Application

2.4.1 Blood disorders

2.4.2 Oncology diseases

2.4.3 Chronic and autoimmune diseases

2.4.4 Growth hormone deficiencies

2.4.5 Others

2.5 Biosimilars/follow-on-biologics Market Size by Application

2.5.1 Global Biosimilars/follow-on-biologics Market Size CAGR by Application

2.5.2 Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)

3 Global Biosimilars/follow-on-biologics by Players

3.1 Biosimilars/follow-on-biologics Market Size Market Share by Players

3.1.1 Global Biosimilars/follow-on-biologics Revenue by Players (2019-2021E)

3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2019-2021E)

3.2 Global Biosimilars/follow-on-biologics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Biosimilars/follow-on-biologics by Regions

4.1 Biosimilars/follow-on-biologics Market Size by Regions (2016-2021)

4.2 Americas Biosimilars/follow-on-biologics Market Size Growth (2016-2021)

4.3 APAC Biosimilars/follow-on-biologics Market Size Growth (2016-2021)

4.4 Europe Biosimilars/follow-on-biologics Market Size Growth (2016-2021)

4.5 Middle East & Africa Biosimilars/follow-on-biologics Market Size Growth (2016-2021)

5 Americas

5.1 Americas Biosimilars/follow-on-biologics Market Size by Country (2016-2021)

5.2 Americas Biosimilars/follow-on-biologics Market Size by Type (2016-2021)

5.3 Americas Biosimilars/follow-on-biologics Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilars/follow-on-biologics Market Size by Region (2016-2021)

6.2 APAC Biosimilars/follow-on-biologics Market Size by Type (2016-2021)

6.3 APAC Biosimilars/follow-on-biologics Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Biosimilars/follow-on-biologics by Country (2016-2021)

7.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021)

7.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilars/follow-on-biologics by Region (2016-2021)

8.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021)

8.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Biosimilars/follow-on-biologics Market Forecast

10.1 Global Biosimilars/follow-on-biologics Forecast by Regions (2021-2026)

10.1.1 Global Biosimilars/follow-on-biologics Forecast by Regions (2021-2026)

10.1.2 Americas Biosimilars/follow-on-biologics Forecast

10.1.3 APAC Biosimilars/follow-on-biologics Forecast

10.1.4 Europe Biosimilars/follow-on-biologics Forecast

10.1.5 Middle East & Africa Biosimilars/follow-on-biologics Forecast

10.2 Americas Biosimilars/follow-on-biologics Forecast by Countries (2021-2026)

10.2.1 United States Biosimilars/follow-on-biologics Market Forecast

10.2.2 Canada Biosimilars/follow-on-biologics Market Forecast

10.2.3 Mexico Biosimilars/follow-on-biologics Market Forecast

10.2.4 Brazil Biosimilars/follow-on-biologics Market Forecast

10.3 APAC Biosimilars/follow-on-biologics Forecast by Region (2021-2026)

10.3.1 China Biosimilars/follow-on-biologics Market Forecast

10.3.2 Japan Biosimilars/follow-on-biologics Market Forecast

10.3.3 Korea Biosimilars/follow-on-biologics Market Forecast

10.3.4 Southeast Asia Biosimilars/follow-on-biologics Market Forecast

10.3.5 India Biosimilars/follow-on-biologics Market Forecast

10.3.6 Australia Biosimilars/follow-on-biologics Market Forecast

10.4 Europe Biosimilars/follow-on-biologics Forecast by Country (2021-2026)

10.4.1 Germany Biosimilars/follow-on-biologics Market Forecast

10.4.2 France Biosimilars/follow-on-biologics Market Forecast

10.4.3 UK Biosimilars/follow-on-biologics Market Forecast

10.4.4 Italy Biosimilars/follow-on-biologics Market Forecast

10.4.5 Russia Biosimilars/follow-on-biologics Market Forecast

10.5 Middle East & Africa Biosimilars/follow-on-biologics Forecast by Region (2021-2026)

10.5.1 Egypt Biosimilars/follow-on-biologics Market Forecast

10.5.2 South Africa Biosimilars/follow-on-biologics Market Forecast

10.5.3 Israel Biosimilars/follow-on-biologics Market Forecast

10.5.4 Turkey Biosimilars/follow-on-biologics Market Forecast

10.5.5 GCC Countries Biosimilars/follow-on-biologics Market Forecast

10.6 Global Biosimilars/follow-on-biologics Forecast by Type (2021-2026)

10.8 Global Biosimilars/follow-on-biologics Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Novartis (Sandoz)

11.1.1 Novartis (Sandoz) Company Information

11.1.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offered

11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Novartis (Sandoz) Main Business Overview

11.1.5 Novartis (Sandoz) Latest Developments

11.2 Synthon Pharmaceuticals

11.2.1 Synthon Pharmaceuticals Company Information

11.2.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offered

11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Synthon Pharmaceuticals Main Business Overview

11.2.5 Synthon Pharmaceuticals Latest Developments

11.3 Teva Pharmaceutical Industries

11.3.1 Teva Pharmaceutical Industries Company Information

11.3.2 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offered

11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Teva Pharmaceutical Industries Main Business Overview

11.3.5 Teva Pharmaceutical Industries Latest Developments

11.4 LG Life Sciences

11.4.1 LG Life Sciences Company Information

11.4.2 LG Life Sciences Biosimilars/follow-on-biologics Product Offered

11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 LG Life Sciences Main Business Overview

11.4.5 LG Life Sciences Latest Developments

11.5 Celltrion Biocon

11.5.1 Celltrion Biocon Company Information

11.5.2 Celltrion Biocon Biosimilars/follow-on-biologics Product Offered

11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Celltrion Biocon Main Business Overview

11.5.5 Celltrion Biocon Latest Developments

11.6 Hospira

11.6.1 Hospira Company Information

11.6.2 Hospira Biosimilars/follow-on-biologics Product Offered

11.6.3 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Hospira Main Business Overview

11.6.5 Hospira Latest Developments

11.7 Merck Serono (Merck)

11.7.1 Merck Serono (Merck) Company Information

11.7.2 Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offered

11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Merck Serono (Merck) Main Business Overview

11.7.5 Merck Serono (Merck) Latest Developments

11.8 Biogen idec

11.8.1 Biogen idec Company Information

11.8.2 Biogen idec Biosimilars/follow-on-biologics Product Offered

11.8.3 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Biogen idec Main Business Overview

11.8.5 Biogen idec Latest Developments

11.9 Genentech (Roche)

11.9.1 Genentech (Roche) Company Information

11.9.2 Genentech (Roche) Biosimilars/follow-on-biologics Product Offered

11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Genentech (Roche) Main Business Overview

11.9.5 Genentech (Roche) Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Biosimilars/follow-on-biologics Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Human growth hormone

Table 3. Major Players of Erythropoietin

Table 4. Major Players of Monoclonal antibodies

Table 5. Major Players of Insulin

Table 6. Major Players of Interferon

Table 7. Major Players of Granulocyte-Colony Stimulating Factor

Table 8. Major Players of Others

Table 9. Biosimilars/follow-on-biologics Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 10. Global Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)

Table 11. Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

Table 12. Biosimilars/follow-on-biologics Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 13. Global Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)

Table 14. Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)

Table 15. Global Biosimilars/follow-on-biologics Revenue by Players (2019-2021E) & ($ Millions)

Table 16. Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2019-2021E)

Table 17. Global Biosimilars/follow-on-biologics Key Players Head office and Products Offered

Table 18. Biosimilars/follow-on-biologics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Biosimilars/follow-on-biologics Market Size by Regions 2016-2021 & ($ Millions)

Table 22. Global Biosimilars/follow-on-biologics Market Size Market Share by Regions 2016-2021

Table 23. Americas Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & ($ Millions)

Table 24. Americas Biosimilars/follow-on-biologics Market Size Market Share by Country (2016-2021)

Table 25. Americas Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)

Table 26. Americas Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

Table 27. Americas Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)

Table 28. Americas Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)

Table 29. APAC Biosimilars/follow-on-biologics Market Size by Region (2016-2021) & ($ Millions)

Table 30. APAC Biosimilars/follow-on-biologics Market Size Market Share by Region (2016-2021)

Table 31. APAC Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)

Table 32. APAC Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

Table 33. APAC Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)

Table 34. APAC Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)

Table 35. Europe Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & ($ Millions)

Table 36. Europe Biosimilars/follow-on-biologics Market Size Market Share by Country (2016-2021)

Table 37. Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)

Table 38. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

Table 39. Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)

Table 40. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)

Table 41. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Region (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Region (2016-2021)

Table 43. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)

Table 44. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

Table 45. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)

Table 46. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)

Table 47. Key and Potential Regions of Biosimilars/follow-on-biologics

Table 48. Key Application and Potential Industries of Biosimilars/follow-on-biologics

Table 49. Key Challenges of Biosimilars/follow-on-biologics

Table 50. Key Trends of Biosimilars/follow-on-biologics

Table 51. Global Biosimilars/follow-on-biologics Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 52. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Regions

Table 53. Global Biosimilars/follow-on-biologics Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 54. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Type (2021-2026)

Table 55. Global Biosimilars/follow-on-biologics Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 56. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Application (2021-2026)

Table 57. Novartis (Sandoz) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 58. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offered

Table 59. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 60. Novartis (Sandoz) Main Business

Table 61. Novartis (Sandoz) Latest Developments

Table 62. Synthon Pharmaceuticals Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 63. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offered

Table 64. Synthon Pharmaceuticals Main Business

Table 65. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Synthon Pharmaceuticals Latest Developments

Table 67. Teva Pharmaceutical Industries Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 68. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offered

Table 69. Teva Pharmaceutical Industries Main Business

Table 70. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Teva Pharmaceutical Industries Latest Developments

Table 72. LG Life Sciences Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 73. LG Life Sciences Biosimilars/follow-on-biologics Product Offered

Table 74. LG Life Sciences Main Business

Table 75. LG Life Sciences Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. LG Life Sciences Latest Developments

Table 77. Celltrion Biocon Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 78. Celltrion Biocon Biosimilars/follow-on-biologics Product Offered

Table 79. Celltrion Biocon Main Business

Table 80. Celltrion Biocon Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Celltrion Biocon Latest Developments

Table 82. Hospira Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 83. Hospira Biosimilars/follow-on-biologics Product Offered

Table 84. Hospira Main Business

Table 85. Hospira Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Hospira Latest Developments

Table 87. Merck Serono (Merck) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 88. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offered

Table 89. Merck Serono (Merck) Main Business

Table 90. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Merck Serono (Merck) Latest Developments

Table 92. Biogen idec Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 93. Biogen idec Biosimilars/follow-on-biologics Product Offered

Table 94. Biogen idec Main Business

Table 95. Biogen idec Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Biogen idec Latest Developments

Table 97. Genentech (Roche) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors

Table 98. Genentech (Roche) Biosimilars/follow-on-biologics Product Offered

Table 99. Genentech (Roche) Main Business

Table 100. Genentech (Roche) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. Genentech (Roche) Latest Developments

List of Figures

Figure 1. Biosimilars/follow-on-biologics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Biosimilars/follow-on-biologics Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)

Figure 7. Biosimilars/follow-on-biologics in Blood disorders

Figure 8. Global Biosimilars/follow-on-biologics Market: Blood disorders (2016-2021) & ($ Millions)

Figure 9. Biosimilars/follow-on-biologics in Oncology diseases

Figure 10. Global Biosimilars/follow-on-biologics Market: Oncology diseases (2016-2021) & ($ Millions)

Figure 11. Biosimilars/follow-on-biologics in Chronic and autoimmune diseases

Figure 12. Global Biosimilars/follow-on-biologics Market: Chronic and autoimmune diseases (2016-2021) & ($ Millions)

Figure 13. Biosimilars/follow-on-biologics in Growth hormone deficiencies

Figure 14. Global Biosimilars/follow-on-biologics Market: Growth hormone deficiencies (2016-2021) & ($ Millions)

Figure 15. Biosimilars/follow-on-biologics in Others

Figure 16. Global Biosimilars/follow-on-biologics Market: Others (2016-2021) & ($ Millions)

Figure 17. Global Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020

Figure 18. Global Biosimilars/follow-on-biologics Revenue Market Share by Player in 2020

Figure 19. Global Biosimilars/follow-on-biologics Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)

Figure 21. APAC Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)

Figure 22. Europe Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)

Figure 24. Americas Biosimilars/follow-on-biologics Market Size Market Share by Country in 2020

Figure 25. Americas Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020

Figure 26. Americas Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020

Figure 27. United States Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Biosimilars/follow-on-biologics Market Size Market Share by Regions in 2020

Figure 31. APAC Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020

Figure 32. APAC Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020

Figure 33. China Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Biosimilars/follow-on-biologics Market Size Market Share by Countries in 2020

Figure 40. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020

Figure 41. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020

Figure 42. Germany Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020

Figure 50. Egypt Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Countries Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 56. APAC Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 57. Europe Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 59. United States Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 60. Canada Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 63. China Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 64. Japan Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 65. Korea Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 67. India Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 68. Australia Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 69. Germany Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 70. France Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 71. UK Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 72. Italy Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 73. Russia Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 74. Spain Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 77. Israel Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)

Figure 79. GCC Countries Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)